Physician profile
James A Dollahite
NPI 1427476902
$6,505.87
in general payments reported to CMS, 2019-2025
16 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,330 · 2020: $35.04 · 2021: $1,240 · 2022: $374 · 2024: $224 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $3,612.00 | 2019 | |
| Alon Medical Technology | $1,590.00 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $415.01 | 2022-2024 | Persona |
| Smith+Nephew, INC. | $280.54 | 2024-2025 | Real Intelligence, Journey II |
| Stryker Corporation | $269.12 | 2019-2025 | Alphavent |
| Bioventus LLC | $64.34 | 2019-2024 | Durolane |
| Depuy Synthes Sales INC. | $44.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $33.96 | 2019-2022 | |
| Acera Surgical, INC. | $32.61 | 2019-2022 | |
| Avanos Medical | $29.53 | 2020-2021 | |
| Conformis, INC. | $27.50 | 2019 | |
| Sawtooth Surgical Solutions INC | $27.35 | 2024 | |
| Orthofix Medical, INC. | $21.86 | 2019 | |
| Vericel Corporation | $21.49 | 2020 | |
| Arthrex, INC. | $21.30 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $15.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dollahite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.